Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > DM ...PROBLEMS IN THE IR AND MARKETING ... solution.. ?
View:
Post by WalkingDead01 on Jan 23, 2021 6:58am

DM ...PROBLEMS IN THE IR AND MARKETING ... solution.. ?

Good morning, like all of you, I'm wondering about Datametrex's news communication problems.  I invested in 2020 in a Biotech that had the IR relationship problems and they seem to have solved this problem with a specialized firm.  Immediately after making this change, there were impressive results.  I communicate the news to you and watch the immediate result of the trend.  Is this the solution for Datametrex ???  I ask myself this question.
 

2020-12-22 
https://vaxil-bio.com/vaxil-retains-investor-engagement-and-marketing-firm/

https://www.stockwatch.com/Quote/Detail?C:VXL

https://northequities.com/

Comment by racetrk6 on Jan 23, 2021 12:01pm
Its a HUGE Problem.   I tried to contact the IR of the company.  Can't even find a phone number to call.  There website does not even provide an email address. It's a bit of a joke.....   If real investors can't talk with IR and they seemingly have NO CLUE on how to Market themselves then how will the stock price ever appriciate.   Even their ...more  
Comment by Kensin1954 on Jan 23, 2021 3:05pm
 mgunter@datametrex.com   Go straight to the top. JMHO
Comment by WalkingDead01 on Jan 23, 2021 3:17pm
Just to clarify my intervention, I am completely satisfied with the work of Marshall Gunter, I believe we have a CEO who will take Datametrex to a very high level.  However I believe he is overloaded right now and needs help with IR.
Comment by MLorenzo on Jan 23, 2021 3:33pm
The problem isn't IR, it's PR. IR is a subset of PR, and IR is the only area of PR that is of any focus at this point. The IR is weak, but there is an attempt. There is absolutely no PR, which is a corproate killer. 1. Corporate Communications. How your business communicates with other businesses, both internally and externally, creates its voice. A corporate communications ...more  
Comment by Kazam1961 on Jan 23, 2021 4:21pm
I maybe wrong however, I thought Todd Shapiro was doing this?
Comment by JAKPUG4LIFE on Jan 23, 2021 6:18pm
He's to busy with Trip. Time for him to go.
Comment by TorlifTostorson on Jan 23, 2021 4:04pm
Sounds good to me. We could show this at the next investors webinar. What will very likely be held shortly after Q4 release. Best Torlif
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities